Mounjaro in Queens, NYthe two-receptor medication, explained
Mounjaro® is tirzepatide, FDA-approved for type 2 diabetes. Zepbound® is the same molecule approved for weight. What makes it different from semaglutide is not marketing — it is a second receptor. Dr. Keisha Bryant, MD prescribes and supervises physician-managed tirzepatide in St Albans.
Why a second receptor changes the maths
Every GLP-1 medication works by amplifying a signal your gut already sends after a meal: you are full, slow down, release insulin. Semaglutide amplifies that one signal. Tirzepatide amplifies two — GLP-1 and GIP, a second gut hormone involved in insulin response and in how the body stores and releases fat.
Two levers instead of one is why the trial numbers look different. In the SURPASS programme, tirzepatide produced substantial reductions in A1C in adults with type 2 diabetes, which is what earned the FDA approval in May 2022. In the SURMOUNT programme, which studied the same molecule for weight, participants averaged roughly 15 to 21% of body weight over 72 weeks. Those are averages across trial populations, over different timeframes, and they are not a promise about you.
Stronger is not automatically better, either. A more powerful medication needs more careful titration, and the side effects that come with dose increases are the reason people quit. That is an argument for a physician who actually knows you, not against the medication.
Mounjaro vs Zepboundone molecule wearing two labels
| Mounjaro® | Zepbound® | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA-approved for | Blood-sugar control in type 2 diabetes | Chronic weight management; moderate-to-severe obstructive sleep apnea in adults with obesity |
| First approved | May 2022 | November 2023 |
| Manufacturer | Eli Lilly | Eli Lilly |
The longer comparison lives on the blog: Mounjaro vs Zepbound in Queens, NY.
Start with the A1C, not the brand
A fair number of people who search Mounjaro are not chasing a dress size. They have type 2 diabetes, their numbers are drifting, and they heard a brand name. That is a different appointment.
Dr. Bryant is board-certified in internal medicine, so the diabetes itself is the starting point — your A1C, the medications you are already on, kidney function, blood pressure, and what has actually been tried. A dual-action medication may or may not belong in that plan. Deciding that properly is why the practice runs diabetes care and weight management under the same roof instead of sending you across the borough.
Already established elsewhere for diabetes? Bring the last labs to the consult. It saves a month.
Who writes it,and what they keep an eye on
A dual-action medication in somebody who is already on diabetes treatment is not a simple add-on. Doses of what you are currently taking may need to come down as this one goes up, and that is a judgment call for a physician who can see the whole medication list, the A1C trend and the kidney numbers in one place.
The prescription is physician-managed tirzepatide — the same active ingredient as Mounjaro and Zepbound — filled by a licensed U.S. pharmacy, because practices write prescriptions and pharmacies dispense them. Which form suits you turns on your history, your coverage and current availability, settled at the consult before anything is written.
- Tirzepatide prescribed by Dr. Bryant, filled by a licensed U.S. pharmacy
- A1C and kidney function tracked alongside the weight, not after it
- Your existing diabetes medications reviewed and adjusted as this one is titrated
- Titration paced to what you tolerate rather than a fixed calendar
- A direct line between visits when a dose does not sit right
Single-action semaglutide is $180/month and is often the better starting point. Dr. Bryant recommends one at the consult rather than selling you the more expensive option by default.
Talk to us first if…
- · You are pregnant, breastfeeding, or planning a pregnancy
- · You have a personal or family history of medullary thyroid cancer or MEN2
- · You have a history of pancreatitis
- · You take other diabetes medications, including insulin or a sulfonylurea, that may need adjusting
Common side effects are mild nausea, indigestion and constipation, usually around a dose increase and easing within about a week. None of the items above are automatic disqualifiers — they are reasons for a careful conversation with a physician before a prescription is written.
Dual-action GLP-1 care in southeast Queens
Type 2 diabetes is not evenly distributed across this city, and southeast Queens carries more of it than most. The neighbourhoods around this office — St Albans, Hollis, Jamaica, Cambria Heights, Springfield Gardens, Queens Village, Laurelton and Rosedale — are exactly the ones where metabolic disease, blood pressure and weight arrive together.
Dr. Bryant Medical Practice and MedSpa sits at 205-15 Hollis Avenue, St Albans, NY 11412. One physician handles the diabetes, the blood pressure and the weight, which means nobody has to reconcile three sets of advice from three offices. If the monthly visit is easier from home, take it as a virtual video visit, or call (929) 547-9616.
Keep reading
The weight and sleep-apnea approvals for the same molecule.
Clinical breakdown, what's included, and pricing.
A1C, medications and monitoring with a board-certified internist.
How to think about one receptor versus two.
Common questions
References & sources
- U.S. Food and Drug Administration — Mounjaro (tirzepatide) approval record, Drugs@FDA
- Jastreboff AM et al. — Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine
- American Diabetes Association — Standards of Care in Diabetes
- National Institute of Diabetes and Digestive and Kidney Diseases — Type 2 diabetes overview
One physician for the weight, the blood sugar and the blood pressure.
Book a free 15-minute consult with Dr. Keisha Bryant, MD in St Albans. She reviews your history and labs and tells you honestly whether a dual-action medication belongs in your plan.
Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Dr. Bryant Medical Practice and MedSpa is not affiliated with, endorsed by, or sponsored by Eli Lilly. Brand names are used here only to identify the medications patients ask about. This page is general health information, not medical advice, and does not replace a consultation with a licensed physician.